Day-Tripping To The Dispensary: Seniors In Pain Hop Aboard The Canna-Bus
Marijuana dispensaries are reaching out to seniors seeking help with the aches and pains of aging. They're discovering an array of products, and some interesting side effects.
Search
Filter
6,581 - 6,600 of 15,447 Results
-
-
New Medicare Advantage Tool To Lower Drug Prices Puts Crimp In Patients’ Choices
Federal officials are allowing the private insurance plans to use “step therapy” for drugs administered by doctors. In step therapy, patients must first use cheaper drugs to see if they work before receiving more expensive options.
By Susan Jaffe -
Half As Many People Are Trying Heroin, But Marijuana Use Grows
An annual government survey of drug use and health shows a dramatic drop in the number of people who tried heroin but an uptick in pot use.
By Jenny Gold -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Discreetly Tracking Down Sex Partners To Stop A Surge In STDs
In response to a spike in syphilis and gonorrhea cases, one Oregon county is sending medical sleuths to break the bad news in person. Some people have no idea they've been exposed to an infection.
-
4 Takeaways On Puerto Rico’s Death Toll, In The Wake Of Trump’s Tweet Storm
The controversy over the death toll from Hurricane Maria continues as the president tweets that the official estimate adopted by territory officials is a political ploy.
-
Podcast: KHN’s ‘What The Health?’ A Detour On A Smoking Off-Ramp
In this episode of KHN’s “What the Health?” Sarah Jane Tribble of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call talk about the Food and Drug Administration’s latest actions to address teenagers’ use of e-cigarettes, Arkansas’ Medicaid work requirements and news about the uninsured from the latest federal Census report.
-
Insurer To Purdue Pharma: We Won’t Pay For OxyContin Anymore
Embattled drugmaker Purdue Pharma defends OxyContin as some insurers are dropping the drug in favor of other abuse-deterrent opioid painkillers.
-
Analysis
Much Touted For Cancer, ‘Precision Medicine’ Often Misses The Target
Doctors and hospitals love to talk about the patients they’ve saved with precision medicine, and reporters love to write about them. But the people who die still vastly outnumber the rare successes.
By Liz Szabo -
Trying To Protect Seniors, The Most Vulnerable, From Formidable Foe Florence
With Hurricane Florence predicted to slam the Southeast's coastline Friday, health officials scramble to dodge the storm and keep older residents safe.
-
In Trump’s First Year, Nation’s Uninsured Rate Unchanged
The Census Bureau reports that the nation’s uninsurance rate was 8.8 percent in 2017 but notes that the rate did increase in 14 states.
-
Doctor To The Stars Disciplined Over Use Of Controversial Menopause Therapy
Dr. Prudence Hall has made a name for herself in the field of “bioidentical hormones” — plant-based compounds purportedly customized for each patient’s needs. Experts say the popular approach is unproven; California regulators say she was grossly negligent in her care of two patients.
-
Unwitting Patients, Copycat Comments Play Hidden Role In Federal Rule-Making
As HHS decided to cut $1.6 billion in drug payments to hospitals, it weighed thousands of comments generated by a pharmaceutical-funded advocacy group.
-
The Remedy For Surprise Medical Bills May Lie In Stitching Up Federal Law
The wide-ranging law has the potential to blindside many consumers whose health care comes from company and union health plans that are “self-funded,” meaning they pay claims out of their own funds.
By Michelle Andrews and Julie Appleby -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Insulin’s Steep Price Leads To Deadly Rationing
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn't afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
-
The High Cost Of Hope: When The Parallel Interests Of Pharma And Families Collide
Desperate for help in finding a lifesaving drug for a fatal genetic disease, families banded together to fund early research and then worked with drug companies on clinical trials and marketing. Yet, this small patient advocacy group is stunned by pharma’s pricing.
By Emily Kopp and Jay Hancock -
Podcast: KHN’s ‘What The Health?’ Health Policy Goes To Court
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico talk about the latest court challenge to the Affordable Care Act, nomination hearings for Supreme Court nominee Brett Kavanaugh and news from the reproductive health front. Plus, Rovner interviews Chad Terhune about the latest KHN/NPR “Bill of the Month” installment.
-
Listen: The GOP Case Against ACA’s Preexisting Condition Protections Begins
Oral arguments got underway in federal court in Fort Worth, Texas, on Wednesday in the lawsuit brought by 20 Republican states seeking to declare the Affordable Care Act unconstitutional.
-
Assisted Living Kicks Out The Frail ’Cause ‘We Can’t Take Care Of You Any Longer’
Is there anything families can do to fight these evictions?